Ratings by B.Riley (Neil Chatterji)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/20/2025 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Stereotaxis | STXS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Paragon 28, Inc | FNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Accuray | ARAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Establishment Labs Inc. | ESTA | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Paragon 28, Inc | FNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | CareCloud | CCLD | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2023 | Butterfly Network | BFLY | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2023 | Establishment Labs Inc. | ESTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2023 | Silk Road Medical | SILK | Downgrade | Neutral (Buy) |
14.09 (27.49) |
95.1% | Details | |
| 9/7/2023 | Koru Medical Systems Inc. | KRMD | New Coverage | Buy (N/A) |
2.55 (3.83) |
50.2% | Details | |
| 8/15/2023 | OptimizeRX | OPRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2023 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2023 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
1.87 (3.71) |
98.4% | Details | |
| 5/11/2023 | ViewRay Inc. | VRAY | Downgrade | Neutral (Buy) |
0.94 (0.03) |
-96.81% | Details | |
| 3/31/2023 | Silk Road Medical | SILK | New Coverage | Buy (N/A) |
38.66 (27.49) |
-28.89% | Details | |
| 3/22/2023 | Hyperfine Inc. | HYPR | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | CareCloud | CCLD | New Coverage | Buy (N/A) |
3.12 (2.22) |
-28.85% | Details | |
| 3/9/2023 | OptimizeRX | OPRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Stereotaxis | STXS | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2023 | Clearpoint Neuro Inc. | CLPT | New Coverage | Buy (N/A) |
9.10 (14.12) |
55.16% | Details | |
| 2/2/2023 | OptimizeRX | OPRX | New Coverage | Buy (N/A) |
18.88 (6.24) |
-66.95% | Details | |
| 12/14/2022 | Paragon 28, Inc | FNA | New Coverage | Buy (N/A) |
19.95 (13.09) |
-34.39% | Details | |
| 11/16/2022 | ViewRay Inc. | VRAY | New Coverage | Buy (N/A) |
4.51 (0.03) |
-99.33% | Details | |
| 10/4/2022 | Hyperfine Inc. | HYPR | New Coverage | Buy (N/A) |
0.81 (0.95) |
17.28% | Details | |
| 10/4/2022 | Butterfly Network | BFLY | New Coverage | Buy (N/A) |
4.70 (6.58) |
40% | Details | |
| 8/24/2022 | Establishment Labs Inc. | ESTA | New Coverage | Buy (N/A) |
62.52 (92.32) |
47.66% | Details | |
| 6/23/2022 | Procept BioRobotics Corp | PRCT | New Coverage | Buy (N/A) |
34.17 (16.69) |
-51.16% | Details | |
| 6/23/2022 | Stereotaxis | STXS | New Coverage | Buy (N/A) |
1.89 (1.29) |
-31.75% | Details | |
| 6/23/2022 | Accuray | ARAY | New Coverage | Buy (N/A) |
1.84 (0.24) |
-86.96% | Details |
